Human Metabolome Technologies, Inc.

Tokyo Stock Exchange 6090.T

Human Metabolome Technologies, Inc. EBT Margin for the year ending June 30, 2024: 19.46%

Human Metabolome Technologies, Inc. EBT Margin is 19.46% for the year ending June 30, 2024, a 6.69% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Human Metabolome Technologies, Inc. EBT Margin for the year ending June 30, 2023 was 18.24%, a -14.80% change year over year.
  • Human Metabolome Technologies, Inc. EBT Margin for the year ending June 30, 2022 was 21.41%, a 372.37% change year over year.
  • Human Metabolome Technologies, Inc. EBT Margin for the year ending June 30, 2021 was 4.53%, a 306.56% change year over year.
  • Human Metabolome Technologies, Inc. EBT Margin for the year ending June 30, 2020 was -2.19%.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
Loading...
Tokyo Stock Exchange: 6090.T

Human Metabolome Technologies, Inc.

CEO Mr. Yasuhiro Ohata
IPO Date Jan. 21, 2014
Location Japan
Headquarters 246-2 Mizukami Kakuganji
Employees 58
Sector Health Care
Industries
Description

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email